Form 4: Zoetis EVP Brannan Reports RSU Vesting, Stock Transactions

Zoetis Inc. Executive Vice President Jamie Brannan reported the vesting of restricted stock units and related stock transactions.

Summary

• Jamie Brannan, Executive Vice President of Zoetis Inc., acquired 1,204 shares of common stock on February 19, 2026, due to the vesting and settlement of restricted stock units (RSUs).
• Concurrently, 566 shares of common stock were disposed of at a price of $127.28 per share on February 19, 2026, likely for tax withholding purposes related to the RSU vesting.
• Following these transactions, Brannan directly owns 3,290 shares of Zoetis Inc. common stock.
• Additionally, Brannan indirectly holds 445 common stock equivalents in the UK Share Ownership Plan as of December 31, 2025.
• The transactions involved the conversion of 1,204.0741 derivative Restricted Stock Units into common stock.
• Remaining derivative securities include 2,410 directly owned RSUs, 5,399 RSUs, and 529 RSUs, all representing contingent rights to receive one share of common stock upon vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports a standard, pre-planned executive compensation event (RSU vesting and tax-related disposition) and does not indicate any new strategic or operational developments for Zoetis Inc.

Positives

• The vesting of Restricted Stock Units represents a realization of compensation for the Executive Vice President, aligning executive interests with shareholder value over time.

Negatives

• A disposition of 566 shares occurred, likely for tax withholding, which reduces the direct beneficial ownership of the executive.

Future Outlook

The filing indicates future vesting events for outstanding Restricted Stock Units on the anniversaries of their respective grant dates (February 19, 2025; February 18, 2026; and February 6, 2024), subject to continued service.

Industry Context

StockSavvy.ai notes that this Form 4 filing details a routine insider transaction related to executive compensation. The vesting of Restricted Stock Units and subsequent tax-related disposition of shares are standard practices within publicly traded companies, particularly in the pharmaceutical and animal health sectors where equity-based compensation is common for retaining and incentivizing key executives.

Related Party Transactions

• The transactions involve the Executive Vice President's compensation in the form of Restricted Stock Units granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine compensation event for an executive, part of the company's established equity incentive plan.
• Employees: No direct impact beyond the reporting person.

Next Steps

• Future tranches of Restricted Stock Units are scheduled to vest on the first, second, and third anniversaries of their grant dates (February 19, 2025; February 18, 2026; and February 6, 2024), contingent on the reporting person's continued service.

Key Dates

Keywords

Zoetis, ZTS, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership